Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Hannah Joseph Hospital IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Hannah Joseph Hospital Limited is a healthcare service provider operating a multi-speciality hospital in Tamil Nadu. The company earns revenue primarily from in-patient services, out-patient consultations, diagnostics, pharmacy sales, and surgical procedures. Its services cater to secondary and tertiary healthcare needs, including critical care, general medicine, surgery, and allied medical services, delivered through a centrally located hospital infrastructure supported by trained medical professionals.
Hannah Joseph Hospital, an Book Built Issue, amounting to ₹
42.00 Crore,consisting entirely an Fresh Issue of
0.60 crore shares of ₹
42.00 Crore,The subscription period for the Hannah Joseph Hospital IPO opens on January 22, 2026, and closes on January 28, 2026. The allotment is expected to be finalized on or about Tuesday, January 29, 2026, and the shares will be listed on the BSE SME with a tentative listing date set on or about Sunday, February 01, 2026,
The Share Price Band of Hannah Joseph Hospital IPO is set at ₹67 to ₹70 per share per equity share. The Market Capitalisation of the Hannah Joseph Hospital at IPO price of ₹70 per equity share will be ₹158.89 Cr. The lot size of the IPO is 1500 shares. Retail investors are required to invest a minimum of ₹
210,000 2 lots (3000 shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is
3 lots (
4500 shares), amounting to ₹
315,000.
CapitalSquare Advisors Private Limited are the book running lead manager of the Hannah Joseph Hospital Ltd. while Bigshare Services Private Limited is the registrar for the issue,The Market Maker of the company is CapitalSquare Financial Services Private Limited.
Hannah Joseph Hospital Limited IPO GMP Today
The Grey Market Premium of Hannah Joseph Hospital IPO is expected to be ₹0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.
Hannah Joseph Hospital Limited IPO Live Subscription Status Today: Real-Time Update
As of 06:30 PM on 28January 2026, the Hannah Joseph Hospital IPO live subscription status shows that the IPO subscribed 1.44 times on its Final Day of subscription period. Check the Hannah Joseph Hospital IPO Live Subscription Status Today at BSE.
Hannah Joseph Hospital Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Hannah Joseph Hospital IPO allotment date is Tuesday, January 29, 2026,Hannah Joseph Hospital IPO Allotment will be out on Tuesday, January 29, 2026,and will be live on Registrar Website from the allotment date.
Bigshare Services Private Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Hannah Joseph Hospital IPO from the dropdown list of IPO
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.
Objectives of Hannah Joseph Hospital Limited IPO
Hannah Joseph Hospital to utilise the Net Proceeds towards the following objects:
1. ₹3,498.21 Lakh is required for Funding of capital expenditure for establishing Radiation Oncology Centre
2. General Corporate Purposes.
Refer to Hannah Joseph Hospital Limited RHP for more details about the Company.
Hannah Joseph Hospital Limited Day Wise IPO GMP Trend
| GMP Date | Issue Price | Expected Listing Price | GMP | Last Updated |
|---|---|---|---|---|
| January 19, 2026 | ₹ 70 | ₹ 70 | ₹0(0.0%) | 19 January 2026; 12:17 PM |
Hannah Joseph Hospital IPO Details
| Market Capitalization | ₹158.89 Cr |
| IPO Date | January 22, 2026 to January 28, 2026 |
| Listing Date | February 01, 2026 |
| Face Value | ₹10 Per Share |
| Price Band | ₹67 to ₹70 |
| Issue Price | ₹70 per share |
| Employee Discount | NA |
| Lot Size | 1500 Equity Shares |
| Total Issue Size | 60,00,000 Equity Shares (aggregating to ₹42.00 Cr) |
| Fresh Issue | 60,00,000 Equity Shares (aggregating to ₹42.00 Cr) |
| Offer for Sale | NA |
| Issue Type | Book Built Issue |
| Listing At | BSE SME |
| Share holding pre issue | 1,66,98,363 |
| Share holding post issue | 2,26,98,363 |
| Rating | Avoid |
Hannah Joseph Hospital IPO Anchor Investors Details
| Bid Date | N/A |
| Shares Offered | N/A |
| Anchor Portion Size (In Cr.) | N/A |
| Anchor lock-in period end date for 50% shares (30 Days) | N/A |
| Anchor lock-in period end date for remaining shares (90 Days) | N/A |
Hannah Joseph Hospital IPO Timeline (Tentative Schedule)
| IPO Open Date | Thu, Jan 22, 2026 |
| IPO Close Date | Tue, Jan 27, 2026 |
| Basis of Allotment | Wed, Jan 28, 2026 |
| Initiation of Refunds | Thu, Jan 29, 2026 |
| Credit of Shares to Demat | Thu, Jan 29, 2026 |
| Listing Date | Fri, Jan 30, 2026 |
| Cut-off time for UPI mandate confirmation | Wed, Jan 28, 2026 |
Hannah Joseph Hospital IPO Reservation
| Investor Category | Shares Offered | Reservation % |
|---|---|---|
| QIB Portion | 2,850,000 | Not less than 50% of the Net Offer |
| Non-Institutional Investor Portion | 855,000 | Not more than 15% of the Net Issue |
| Retail Shares Offered | 1,995,000 | Not more than 35% of the Net Offer |
| Market Maker Portion | 300,000 | - |
Hannah Joseph Hospital IPO Promoter Holding
| Share Holding Pre Issue | 93.57% |
| Share Holding Post Issue | 68.83% |
Hannah Joseph Hospital IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 3,000 | ₹210,000 |
| Retail (Max) | 2 | 3,000 | ₹210,000 |
| S-HNI (Min) | 3 | 4,500 | ₹315,000 |
| S-HNI (Max) | 9 | 13,500 | ₹945,000 |
| B-HNI (Min) | 10 | 15,000 | ₹1,050,000 |
Hannah Joseph Hospital IPO Subscription Status
| Investor Category | Shares Offered | Shares Bid For | No of Times Subscribed | Last Upadeted |
|---|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 11,40,000 | 12,30,000 | 1.08x | 29 January 2026; 10:31 AM |
| Non Institutional Investors(NIIS) | 11,58,000 | 17,02,000 | 1.47x | 29 January 2026; 10:31 AM |
| Retail Individual Investors (RIIs) | 19,96,000 | 32,32,000 | 1.62x | 29 January 2026; 10:31 AM |
| Total | 42,94,000 | 61,64,000 | 1.44x | 29 January 2026; 10:32 AM |
About Hannah Joseph Hospital Limited
Hannah Joseph Hospital Limited is a healthcare service provider operating a multi-speciality hospital in Tamil Nadu. The company earns revenue primarily from in-patient services, out-patient consultations, diagnostics, pharmacy sales, and surgical procedures. Its services cater to secondary and tertiary healthcare needs, including critical care, general medicine, surgery, and allied medical services, delivered through a centrally located hospital infrastructure supported by trained medical professionals.
Key Clients & Manufacturing / Operating Facilities
The company primarily serves walk-in patients, corporate-insured patients, and government-scheme beneficiaries. Hannah Joseph Hospital operates a single integrated hospital facility located in Tamil Nadu, equipped with operation theatres, diagnostic labs, pharmacy, ICU beds, and patient wards. The facility is designed to support end-to-end patient care, including diagnosis, treatment, surgery, recovery, and follow-up services under one roof.
Product / Service Portfolio & Order Book Execution
The hospital’s service portfolio includes OPD consultations, IPD services, surgical procedures, diagnostics, pharmacy, and critical care services. These services support the full healthcare lifecycle of patients, from early diagnosis to post-treatment care. As a hospital business, there is no traditional order book; revenue execution depends on patient footfall, bed occupancy rates, surgical volumes, and efficient utilisation of medical infrastructure.
Mergers, Capex & Expansion Plans
The company has not undertaken any mergers or acquisitions to date. The IPO proceeds are proposed to be utilised mainly for capital expenditure, including medical equipment purchase, facility upgrades, working capital requirements, and general corporate purposes. The expansion strategy focuses on improving service capacity, operational efficiency, and patient care quality rather than aggressive geographical expansion in the near term.
Employees & Banker Details
November 30, 2025, the company had 364 employees. The Banker to the Company is IDBI Bank Limited.
Management & Vision
The management of Hannah Joseph Hospital Limited is focused on building a patient-centric healthcare model with emphasis on service quality, affordability, and operational efficiency. Their near-term vision includes improving bed utilisation, expanding diagnostic and surgical capabilities, and strengthening doctor engagement. Long-term targets include scaling revenues through higher patient volumes and selective capacity expansion. Funding for capex and growth will be arranged through IPO proceeds, internal accruals, and prudent debt, while maintaining balance-sheet discipline.
Industry Overview
Hannah Joseph Hospital operates in the Indian healthcare and hospital services industry, one of the fastest-growing sectors in India. The Indian healthcare market is valued at USD 370–400 billion and is expected to grow at a CAGR of 8–10%, driven by rising population, ageing demographics, lifestyle diseases, and increased insurance penetration.
The hospital segment contributes a significant share, supported by growing demand for secondary and tertiary care. Major Indian hospital players include Apollo Hospitals, Fortis Healthcare, Narayana Health, and Aster DM Healthcare. Globally, the healthcare industry exceeds USD 10 trillion, with steady long-term growth driven by medical innovation and rising healthcare access.
Key Risk Factors
- Dependence on Single Hospital Facility
The company currently operates from a single hospital location. Any disruption due to regulatory, operational, or local issues could materially impact revenues and overall business continuity. - Regulatory and Compliance Risk
Healthcare operations are subject to strict regulations, licensing requirements, and clinical standards. Any non-compliance may lead to penalties, suspension of services, or reputational damage. - Doctor and Skilled Staff Retention Risk
The business depends heavily on qualified doctors and medical staff. Inability to attract or retain skilled professionals may adversely affect service quality and patient volumes. - Revenue Volatility Due to Patient Footfall
Hospital revenues depend on patient inflow, bed occupancy, and surgery volumes, which may fluctuate due to competition, seasonal trends, or external health events. - Competition from Established Hospital Chains
The company faces competition from larger, well-capitalised hospital chains offering wider service portfolios, stronger brand recall, and better bargaining power. - Cost Inflation in Medical Supplies
Rising costs of medical equipment, consumables, and pharmaceuticals may impact operating margins if the company is unable to pass on cost increases to patients.
Key Strengths, Moat & Opportunities
- Integrated Healthcare Service Model
The hospital offers diagnostics, consultations, surgery, pharmacy, and post-care services under one roof, enabling better patient experience and higher revenue per patient. - Growing Demand for Affordable Healthcare
Rising healthcare awareness, insurance coverage, and government health schemes create strong demand for affordable multi-speciality hospitals in semi-urban and urban regions. - Efficient Utilisation of Existing Infrastructure
Management focus on improving bed occupancy, diagnostic utilisation, and surgical throughput can drive revenue growth without heavy capital investment. - Experienced Medical and Operational Team
The presence of trained doctors, nurses, and operational staff supports consistent service delivery and helps build patient trust and repeat footfall. - Scalable Business Model
The hospital model allows future expansion through capacity enhancement, additional departments, or satellite clinics, offering long-term scalability. - IPO-Led Balance Sheet Strengthening
IPO proceeds will strengthen working capital, support capex, and improve financial flexibility, enabling sustainable growth with controlled leverage.
Hannah Joseph Hospital Limited Financial Information (Restated Consolidated)
Amount in (₹ in Lakhs)
| Period Ended | Sep 30, 2025 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|---|
| Reserve of Surplus | 4,035.69 | 3,523.83 | 2,901.50 | 1,820.22 |
| Total Assets | 10,458.09 | 9,929.24 | 8,996.80 | 9,214.24 |
| Total Borrowings | 3,164.08 | 3,357.95 | 3,138.64 | 4,295.46 |
| Fixed Assets | 6,606.06 | 6,846.41 | 6,527.65 | 7,115.55 |
| Cash | 1,181.89 | 761.74 | 468.19 | 386.46 |
| Cash flow from operating activities | 1,000.00 | 1,960.00 | 804.00 | 2,081.00 |
| Cash flows from investing activities | -153.00 | -1,349.00 | -360.00 | -496.00 |
| Cash flow from financing activities | -427.00 | -318.00 | -262.00 | -1,043.00 |
| Net Borrowing | 1,982.19 | 2,596.21 | 2,670.45 | 3,909.00 |
| Revenue | 4,275.47 | 7,790.05 | 6,362.81 | 5,489.68 |
| EBITDA | 1,165.02 | 2,051.96 | 1,797.75 | 1,638.07 |
| PAT | 511.86 | 720.99 | 406.64 | 101.06 |
| PAT Margin | 11.97% | 9.26% | 6.39% | 1.84% |
| EPS | 3.07 | 4.32 | 2.47 | 0.63 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue Data, given in FINANCIAL EXPRESS.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 4.32 |
| EPS Post IPO (Rs.) | 3.18 |
| Adjusted 12M EPS Post IPO (Rs.) | 4.51 |
| P/E Pre IPO | 16.20 |
| P/E Post IPO | 22.04 |
| Adjusted 12M P/E Post IPO | 15.52 |
| ROE | 14.77% |
| ROCE | 17.03% |
| P/BV | 2.39 |
| Debt/Equity | 0.65 |
| RoNW | 14.74% |
| EBITDA Margin | 26.47% |
| PAT Margin | 9.26% |
Hannah Joseph Hospital Limited IPO Peer Comparison
| Company Name | EPS | P/E (x) | ROE | ROCE | P/BV | Debt/Equity | RoNW (%) |
|---|---|---|---|---|---|---|---|
| Hannah Joseph Hospital | 3.18 | 22.04 | 14.77% | 17.03% | 2.39 | 0.65 | 14.74% |
| Asarfi Hospital | 5.58 | 32.26 | 14.1 % | 15.8 % | 4.39 | 0.54 | 13.48% |
| Maitreya Medicare | 2.80 | 74.29 | 7.17 % | 10.8 % | 5.33 | 0.14 | 7.10% |
Hannah Joseph Hospital Limited Contact Details
Hannah Joseph Hospital Limited
Phone: 9524729594
Email: cs@hannahjosephhospital.com
Website: https://hannahjosephhospital.com
Hannah Joseph Hospital IPO Registrar and Lead Manager(s)
Bigshare Services Private Limited
Phone: +91 – 22 – 6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com
CapitalSquare Advisors Private Limited
Phone: 022 6684 9999/ 022 6684 9946
Email: mb@capitalsquare.in
Website: http://www.capitalsquare.in/
Hannah Joseph Hospital IPO Review
Hannah Joseph Hospital Limited is a healthcare service provider operating a multi-speciality hospital in Tamil Nadu. The company earns revenue primarily from in-patient services, out-patient consultations, diagnostics, pharmacy sales, and surgical procedures. Its services cater to secondary and tertiary healthcare needs, including critical care, general medicine, surgery, and allied medical services, delivered through a centrally located hospital infrastructure supported by trained medical professionals.
The Company is led by Promoter, i.e.,Mosesjoseph Arunkumar, Fenn Kavitha Fenn Arunkumar, Arunkumar Nalina and Noyel Arunkumar
The Revenues from operations for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 4,275.47 Lakh, ₹ 7,790.05 Lakh, ₹ 6,362.81 Lakh, and ₹ 5,489.68 Lakh, The EBITDA for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 1,165.02 Lakh, ₹ 2,051.96 Lakh, ₹ 1,797.75 Lakh, and ₹ 1,638.07 Lakh, The Profit after Tax for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 511.86 Lakh, ₹ 720.99 Lakh, ₹ 406.64 Lakh, and ₹ 101.06 Lakh, respectively. This indicates a steady growth in financial performance.
The Company Key Performance Indicates the pre-issue EPS of ₹ 4.32 and post-issue EPS of ₹ 3.18 for FY25. The pre-issue P/E ratio is 16.20x,while the post-issue P/E ratio is 22.04x against the Industry P/E ratio is 53.28x The company's ROE for FY25 is 14.77% and RoNW is 14.74% The Annualised EPS is ₹ 4.51x and P/E is ₹ 15.52x, These metrics suggest that the IPO is Fully priced.
The Grey Market Premium (GMP) of Hannah Joseph Hospital showing listing gains of 0%.Given the company's financial performance and the valuation of the IPO, we recommend Investors to Avoid to the Hannah Joseph Hospital Limited. IPO for Listing gain or Long Term Purposes.
Disclaimer: The information provided in this IPO review is for educational and informational purposes only and should not be construed as financial advice or an offer to buy or sell securities. The review must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. The content is based on publicly available information and market perceptions as of the date of publication and is subject to change. Neither the author nor the website is responsible for any losses or damages arising from the use of this information. We also use Artificial Intelligence (AI) tools to enhance the efficiency and quality of our research services, including data retrieval, analysis, and report summarization. 1.“Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.” 2. “Investment in securities market are subject to market risks. Read all the related documents carefully before investing.” 3. To read the Disclaimers, Disclosures, Investor Charter, Investor Complaints please visit Legal our website abhayvarn.com
About the Author
CA Abhay Kumar (Also known as CA Abhay Varn) is a qualified Chartered Accountant by profession and cleared CA at age 21. He is a SEBI Registered Research Analyst with Registration Number - INH300008465. He Possesses 8+ years of experience in the Stock Market Field and has also worked in Big CA firms.





